Marker Therapeutics Inc (MRKR)

[microcapbiotech]

Can someone explain how this is legal?

OK, Last Wednesday 4-17, Moleculin Announces Significant Discovery in Lung Cancer Models (very early mouse models), and the next day 4-18, Moleculin Biotech Gets FDA Fast Track Designation for Annamycin.

Stock goes from $1.00 to $1.40 - OK that makes sense.

THEN, yesterday, Moleculin Announces Conference Call to Discuss Significant Discovery For Lung Cancer and FDA Activity on Wednesday, April 24, 2019.

NOW, the conference call (tomorrow) will discuss WHAT THEY ALREADY ANNOUNCED on 4-17 and 4-18.

And yesterday. for some idiotic reason, the stocks goes up to past $3.00 … because of 2 reasons, #1 people who thought this was NEW news and didn't realize they already announced it last week, and #2 momentum players, the trend is your friend.

Today, stock dumps back down to 1.59.

OK, NOW, here is the part I question the legality of.

TODAY, Moleculin Announces $15.0 Million Registered Direct Offering, of 9,375,000 units at a public offering price of $1.60 per unit in a registered direct offering. Each unit is comprised of one share of common stock and 0.5 of a warrant to purchase one share of common stock.

HOW is it legal for the company ITSELF to artificially raise the stock price with a bogus announcement that they ALREADY made several days before and then take advantage of that higher price in order to have a stock offering at a price higher than the stock would have otherwise been?

It seems to me that the stock offering was planned before hand, they made their FIRST announcements on 4-17 and 4-18, but the stock did not go as high as they hoped, so they make a second bogus announcement to drive the stock price higher. How is that legal?